hivandhepatitis.com

Error
  • Article not found
Coverage of Digestive Disease Week 2013

Coverage of Digestive Disease Week 2013

HIVandHepatitis.com coverage of the 2013 Digestive Disease Week annual meeting (DDW 2013) in Orlando, Florida, May 18-21, 2013.

Conference highlights include direct-acting hepatitis C drugs, new strategies for using approved HCV protease inhibitors and interferon/ribavirin, and interferon-free regimens.

Full listing by topic

HIVandHepatitis.com DDW 2013 conference section

5/22/13

 

READ MORE...

New NRTI BMS-986001 Potently Suppresses HIV in Early Monotherapy Study

New NRTI BMS-986001 Potently Suppresses HIV in Early Monotherapy Study

Young people with HIV are less likely to access and benefit from HIV care and treatment at all levels of the "care cascade" from testing to starting antiretroviral therapy (ART) to achieving viral suppression, according to findings reported in the June 17, 2013, advance edition of JAMA Internal Medicine . Overall, only about 25% of HIV positive people achieved undetectable viral load.

READ MORE...

Antiretroviral PrEP Prevents HIV Transmission among Injection Drug Users

Antiretroviral PrEP Prevents HIV Transmission among Injection Drug Users

Pre-exposure prophylaxis (PrEP) using daily oral tenofovir (Viread) reduced the risk of HIV acquisition among injection drug users in Thailand by half, according to findings from the Bangkok Tenofovir Study, published in the June 13, 2013, advance online edition of The Lancet . These findings led the CDC to recommend that PrEP be "considered as one of several prevention options for persons at very high risk for HIV acquisition" through injection drug use.

READ MORE...

Coverage of the 2013 EASL International Liver Congress

Coverage of the 2013 EASL International Liver Congress

HIVandHepatitis.com coverage of the 48th Annual Meeting of the European Association for the Study of the Liver (EASL 2013) in Amsterdam, April 24-28, 2013.

Conference highlights include treatment for hepatitis B and C, new direct-acting HCV drugs, interferon-free hepatitis C therapy, management of liver disease complications, and prevention and treatment of hepatocellular carcinoma.

Full listing by topic

EASL 2013 conference section

4/27/13

 

READ MORE...

CROI 2013: Functional Cure of HIV-infected Infant after Early ART [VIDEO]

CROI 2013: Functional Cure of HIV-infected Infant after Early ART [VIDEO]

The big news on the opening day of the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) was a report about an infant with HIV who started combination antiretroviral treatment very early and now shows no evidence of replication-competent virus. "We equate this to our Berlin Patient," said Deborah Persaud from Johns Hopkins University School of Medicine. "It could get us on the road to a cure for HIV-infected children."

READ MORE...

1 of 5 Loading
Coverage of the 2013 Conference on Retroviruses and Opportunistic Infections

Coverage of the 2013 Conference on Retroviruses and Opportunistic Infections

Younger People with HIV Are Missing Out in the Continuum of Care

Younger People with HIV Are Missing Out in the Continuum of Care

People with Well-Controlled HIV Can Match Lifespan of HIV Negatives

People with Well-Controlled HIV Can Match Lifespan of HIV Negatives

30 Years of HIV: Long Road Ahead to a Cure

30 Years of HIV: Long Road Ahead to a Cure

HIV Treatment Outcomes Improving among Transgender People

HIV Treatment Outcomes Improving among Transgender People

Low Vitamin D Linked to Greater Hepatitis B Virus Replication

Low Vitamin D Linked to Greater Hepatitis B Virus Replication

Directly Observed Therapy for Tuberculosis No Better than Self-Administration

Directly Observed Therapy for Tuberculosis No Better than Self-Administration

HIV/AIDS

Setting

HIV Treatment

GRACE Survey Sheds Light on Treatment Benefits and Barriers for HIV+ Women

Caring for children, unemployment, and transportation difficulties were among th...

MORE:

HIV Prevention

Some Men Shed HIV in Semen Despite ART, Linked to Herpesvirus Coinfection

About 10% of gay men in a U.S. study had detectable HIV in their semen despite s...

MORE:

HIV Testing & Diagnosis

U.S. Preventive Services Task Force Recommends Routine HIV Screening for Adolescents and Adults

On April 30 the U.S. Preventive Services Task Force (USPSTF) issued a "Grad...

MORE:

HIV Disease Progression

Lack of Food Linked to More Hospitalizations among HIV+ People with Unstable Housing

Homeless and marginally housed people with HIV in San Francisco who experienced ...

MORE:

Hepatitis B

Setting

HBV Treatment

DDW 2003: Tenofovir and Entecavir Effectively Suppress Hepatitis B Virus

The newer antivirals tenofovir (Viread) and entecavir (Baraclude) inhibit hepati...

MORE:

HBV Prevention

FDA Rejects Heplisav Hepatitis B Vaccine Seeking More Safety Data

The U.S. Food and Drug Administration (FDA) has declined to approve Dynavax...

MORE:

HBV Testing & Diagnosis

National Hepatitis Testing Day: Most Infected Are Unaware, All Boomers Should Get HCV Test

In advance of the National Hepatitis Testing Day on Saturday, May 19, the U.S. C...

MORE:

HBV Disease Progression

Everolimus (Zortress) Approved to Prevent Liver Transplant Rejection

The U.S. Food and Drug Administration (FDA) this month approved the immunos...

MORE:

Hepatitis C

Setting

HCV Treatment

EASL 2013: 12 Weeks of Telaprevir Triple Therapy Adequate for Some Hep C Patients

Nearly 90% of genotype 1 chronic hepatitis C patients with favorable response fa...

MORE:

HCV Prevention

War on Drugs Is Major Driver of Global Hepatitis C Epidemic

The so-called "war on drugs" plays a major role is sustaining hepatiti...

MORE:

HCV Testing & Diagnosis

Sunday is Hepatitis Testing Day -- All Baby Boomers Should Get Hep C Test

May 19 is the second annual Viral Hepatitis Testing Day, an opportunity to raise...

MORE:

HCV Disease Progression

EASL 2013: HIV/HCV Coinfected Patients More Likely to Develop Cirrhosis, but Treatment Lowers Risk

Sustained response to hepatitis C treatment leads to slow regression of liver fi...

MORE:

HIV/Hepatitis Coinfection

Setting

HIV/HBV Coinfection

Tenofovir plus Emtricitabine or Lamivudine Does Not Always Suppress Hepatitis B in HIV/HBV Coinfected

HIV/HBV coinfected people with high hepatitis B virus (HBV) levels and those who...

MORE:

HIV/HCV Coinfection

EASL 2013: HIV/HCV Coinfected at Risk for Decompensation, May Need Prompt Treatment

HIV positive people with hepatitis C coinfection may experience liver&...

MORE:

HBV/HCV Coinfection

Adefovir plus Hepatitis C Therapy May Prevent HBV Reactivation in HBV-HCV Coinfected Patients

Due to the similar transmission routes, many people are dually infected with bot...

Other Health News

Setting

Tuberculosis (TB)

Vitamin C Rapidly Kills Drug-resistant Tuberculosis Bacteria

Vitamin C causes a chemical reaction that rapidly destroys  Mycobacterium &nb...

MORE:

Human Papillomavirus (HPV)

Star Calls Attention to Oral Sex Throat Cancer Link, Raising Awareness of HPV Vaccine

Actor Michael Douglas' claim that his throat cancer was caused by oral sex h...

MORE:

Other STDs

Drug-resistant Gonorrhea Makes its Way into North America

The first documented failure of oral treatment for gonorrhea in North America ha...

MORE:

Influenza

2012-2013 Could Be Bad Flu Season, Not Too Late to Get Vaccine, CDC Advises

Significant increases in influenza activity in the U.S. during the past 2 weeks ...

MORE:
Copyright © 2013 hivandhepatitis.com. All Rights Reserved. Designed by JoomlArt.com. Joomla! is Free Software released under the GNU General Public License.

Bread and Roses Web DesignWeb Design and Development by Bread and Roses Web Design